COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,019 Articles (22,627 medRxiv, 8,392 bioRxiv)

Most recent first Previous |  Page 2831: Articles 28301-28310  | Next

Full-spectrum dynamics of the coronavirus disease outbreak in Wuhan, China: a modeling study of 32,583 laboratory-confirmed cases
Hao, X., Cheng, S., Wu, D., Wu, T., Lin, X., Wang, C.
10.1101/2020.04.27.20078436 — Posted: 2020-05-04
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19
Huang, M., Li, M., Xiao, F., Liang, J., Pang, P., Tang, T., Liu, S., Chen, B., Shu, J., You, Y., Li, Y., Tang, M., Zhou, J., Jiang, G., Xiang, J., Hong, W., He, S., Wang, Z., Feng, J., Lin, C., Ye, Y., Wu, Z., Li, Y., Zhong, B., Sun, R., Hong, Z., Liu, J., Chen, H., Wang, X., Li, Z., Pei, D., Tian, L., Xia, J., Jiang, S., Zhong, N., Shan, H.
10.1101/2020.04.26.20081059 — Posted: 2020-05-04 Discussion: Onsite
Enzyme immunoassay for SARS-CoV-2 antibodies in dried blood spot samples: A minimally-invasive approach to facilitate community- and population-based screening
McDade, T. W., McNally, E., D'Aquila, R. T., Mustanski, B., Miller, A., Vaught, L., Reiser, N., Bogdanovic, E., Zelikovich, A., Demonbreun, A.
10.1101/2020.04.28.20081844 — Posted: 2020-05-04
COVID-19 Pandemic Response Simulation: Impact of Non-pharmaceutical Interventions on Ending Lockdowns
Lee, S., Zabinsky, Z. B., Kofsky, S. M., Liu, S.
10.1101/2020.04.28.20080838 — Posted: 2020-05-04
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes
Wang, Z., Zheutlin, A. B., Kao, Y.-H., Ayers, K. L., Gross, S. J., Kovatch, P., Nirenberg, S., Charney, A. W., Nadkarni, G. N., O'Reilly, P. F., Just, A. C., Horowitz, C. R., Martin, G., Branch, A. D., Glicksberg, B. S., Charney, D. S., Reich, D. L., Oh, W. K., Schadt, E. E., Chen, R., Li, L.
10.1101/2020.04.28.20075788 — Posted: 2020-05-04 Discussion: Onsite
Population vulnerability to COVID-19 in Europe: a burden of disease analysis
Wyper, G. M., Assuncao, R. M., Cuschieri, S., Devleeschauwer, B., Fletcher, E., Haagsma, J. A., Hilderink, H., Idavain, J., Lesnik, T., Von der Lippe, E., Majdan, M., Milicevic, M. S., Pallari, E., Penalvo, J. L., Pires, S. M., Plass, D., Santos, J. V., Thomsen, S. T., Stockton, D. L., Grant, I.
10.1101/2020.04.29.20064279 — Posted: 2020-05-04 Discussion: Offsite
Balancing revenue generation with capacity generation: Case distribution, financial impact and hospital capacity changes from cancelling or resuming elective surgeries in the US during COVID-19
TONNA, J. E., Hanson, H. A., Cohan, J. N., McCrum, M. L., Horns, J. J., Brooke, B. S., Das, R., Kelly, B. C., Campbell, A. J., Hotaling, J.
10.1101/2020.04.29.20066506 — Posted: 2020-05-04
Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020
Glaziou, P.
10.1101/2020.04.28.20079582 — Posted: 2020-05-04
AKI during COVID-19 infection: low incidence, high risk of death
Mou, Z., Zhang, X.
10.1101/2020.04.29.20079038 — Posted: 2020-05-04
Negative impact of hyperglycemia on Tocilizumab therapy in COVID-19 patients
Marfella, R., Paolisso, P., Sardu, C., Bergamaschi, L., D' Angelo, E. C., Barbieri, M., Rizzo, M. R., Messina, V., Maggi, P., Coppola, N., Pizzi, C., Biffi, M., Viale, P. L., Galie, N., Paolisso, G.
10.1101/2020.04.29.20076570 — Posted: 2020-05-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).